Join
Live feed
·
INSIDERFilingvia Quantisnow
Finch Therapeutics Group Inc. logo

SEC Form 4: Blaustein Marc sold $1,755 worth of shares (4,619 units at $0.38), decreasing direct ownership by 14% to 27,995 units (tax withholding)

ByQuantisnow·Wall Street's wire, on your screen.
FNCH· Finch Therapeutics Group Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FNCH (Finch Therapeutics Group Inc.) and more on Quantisnow.